1. Home
  2. ALLR vs BATL Comparison

ALLR vs BATL Comparison

Compare ALLR & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • BATL
  • Stock Information
  • Founded
  • ALLR 2004
  • BATL 1987
  • Country
  • ALLR United States
  • BATL United States
  • Employees
  • ALLR N/A
  • BATL N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • BATL Oil & Gas Production
  • Sector
  • ALLR Health Care
  • BATL Energy
  • Exchange
  • ALLR Nasdaq
  • BATL Nasdaq
  • Market Cap
  • ALLR 20.2M
  • BATL 21.2M
  • IPO Year
  • ALLR N/A
  • BATL N/A
  • Fundamental
  • Price
  • ALLR $1.23
  • BATL $1.12
  • Analyst Decision
  • ALLR Strong Buy
  • BATL
  • Analyst Count
  • ALLR 1
  • BATL 0
  • Target Price
  • ALLR $9.25
  • BATL N/A
  • AVG Volume (30 Days)
  • ALLR 262.6K
  • BATL 441.2K
  • Earning Date
  • ALLR 11-14-2025
  • BATL 11-13-2025
  • Dividend Yield
  • ALLR N/A
  • BATL N/A
  • EPS Growth
  • ALLR N/A
  • BATL N/A
  • EPS
  • ALLR N/A
  • BATL N/A
  • Revenue
  • ALLR N/A
  • BATL $185,206,000.00
  • Revenue This Year
  • ALLR N/A
  • BATL N/A
  • Revenue Next Year
  • ALLR N/A
  • BATL N/A
  • P/E Ratio
  • ALLR N/A
  • BATL N/A
  • Revenue Growth
  • ALLR N/A
  • BATL N/A
  • 52 Week Low
  • ALLR $0.61
  • BATL $1.00
  • 52 Week High
  • ALLR $2.35
  • BATL $6.84
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 40.99
  • BATL 47.55
  • Support Level
  • ALLR $1.09
  • BATL $1.09
  • Resistance Level
  • ALLR $1.45
  • BATL $1.11
  • Average True Range (ATR)
  • ALLR 0.09
  • BATL 0.09
  • MACD
  • ALLR -0.02
  • BATL -0.01
  • Stochastic Oscillator
  • ALLR 37.42
  • BATL 13.07

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.

Share on Social Networks: